DETECTION OF HEPATIC INSULIN RESISTANCE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120269720A1
SERIAL NO

13388373

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are methods for determining whether a subject may have hepatic insulin resistance, for diagnosing hepatic insulin resistance, and for assessing the prognosis of a subject with hepatic insulin resistance, comprising determining the level of expression of major facilitator superfamily domain 2 protein (Mfsd2) in a subject's liver, where overexpression of Mfsd2 is indicative of hepatic insulin resistance.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY1300 MORRIS PARK AVENUE BRONX NY 10461

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Silver, David L Singapore, SG 3 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation